Seres Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,654.00
114,185.00
205,082.00
193,243.00
149,983.00
85,820
Other Current Assets
51.00
58.00
2,528.00
5,126.00
5,095.00
6,845
Total Current Assets
1,705.00
114,243.00
207,610.00
198,369.00
155,078.00
92,665
Net Property, Plant & Equipment
352.00
1,264.00
7,751.00
36,125.00
32,931.00
26,294
Total Investments and Advances
37.00
139.00
1,539.00
38,152.00
1,513.00
1,513
Other Assets
31.00
1,699.00
-
-
-
-
Total Assets
2,125.00
117,345.00
216,900.00
272,646.00
189,522.00
120,472
ST Debt & Current Portion LT Debt
400.00
1,200.00
-
-
-
Accounts Payable
-
-
-
7,587.00
7,033.00
Other Current Liabilities
656.00
3,903.00
10,920.00
22,870.00
24,592.00
Total Current Liabilities
1,056.00
5,103.00
10,920.00
30,457.00
31,625.00
Long-Term Debt
602.00
2,886.00
-
-
-
Other Liabilities
-
-
586.00
109,558.00
97,198.00
Total Liabilities
1,658.00
7,989.00
11,506.00
140,015.00
128,823.00
Common Equity (Total)
11,116.00
26,721.00
205,394.00
132,631.00
60,699.00
Total Shareholders' Equity
467.00
109,356.00
205,394.00
132,631.00
60,699.00
Total Equity
467.00
109,356.00
205,394.00
132,631.00
60,699.00
Liabilities & Shareholders' Equity
2,125.00
117,345.00
216,900.00
272,646.00
189,522.00
Preferred Stock (Carrying Value)
11,583.00
136,077.00
-
-
-
About Seres Therapeutics
View Profile
